McMurray J.J., Solomon S.D., Inzucchi S.E., et al
We prescribe lots of things that are more complicated or more dangerous than GLP-1s
Manufacturer coupons and savings programs sometimes reduce out-of-pocket costs for insured patients, but these programs often exclude government payers
It is usually a covered medication, but prices may still be high, especially before patients have hit their premiums or in the Medicare coverage gap (donut hole)
The EMAs review, launched in December 2024, found that the risk of developing NAION more than doubled in patients taking semaglutide compared to those on other diabetes medications, with an estimated frequency of up to 1 in 10,000
Was the CBD used in this trial the same as what is in retail products